Data generated by high throughput methods like mass-spectrometry, second-40 generation sequencing, or microarrays are sensitive to experimental and 41 computational processing [1, 2]. This sensitivity gives rise to 'batch effects' 42
taken from the built environment [13] , where populations are under-sampled, the 66 biological signal is relatively weak, and batch effects can be quite large [14] . One 67 way to get around this issue is to calculate statistics within a given batch, and 68 then compare significant features across batches using classic meta-analysis 69 techniques for combining p-values, like Fisher's and Stouffer's methods [15, 16] . 70
These meta-analysis techniques are robust to batch effects across independent 71 studies, but have less statistical power and ability to detect subtle differences 72 than directly pooling data across studies. 73
Here, we describe a model-free data-normalization procedure for 74 controlling batch effects in case-control microbiome studies that enables pooling 75 data across studies. Case-control studies include a built-in population of control 76 samples (e.g. healthy subjects) that can be used to normalize the case samples 77 (e.g. diseased subjects). For every feature (i.e. bacterial taxon), the case 78 abundance distributions can be converted to percentiles of the equivalent control 79 abundance distributions (Fig. 1) . Study-specific batch effects present in the case 80 samples will also be present in the control samples, and by converting the case 81 data into percentiles of the control distribution these effects are mitigated. Upon 82 conversion to percentiles of the within-study controls, percentile-normalized 83 samples from multiple studies with similar case-control definitions can be more 84 appropriately pooled for statistical testing (Fig. 1) . We show that this approach 85 effectively controls batch effects in microbiome case-control studies and we 86 compare this method to pooling ComBat-or limma-corrected data, and to 87
Fisher's and Stouffer's methods for combining independent p-values. 88 (OTU 1) abundance distributions for control samples and case samples from two 93 independent studies. Converting a control distribution into percentiles of itself 94 naturally gives rise to a uniform distribution (represented by flat blue distributions 95 in central panels), while converting the case distribution into percentiles of the 96 control distribution produces a non-uniform distribution when these two 97 distributions differ (represented by skewed orange distributions in central panels).
98
The right-most panel shows the result of pooling percentile distributions from
To plot data in ordination space, Bray-Curtis distances were calculated 137 from relative abundance data using Scikit-learn 138 (sklearn.metrics.pairwise.pairwise_distances; metric='braycurtis') [39] . Non-139 metric multidimensional scaling (NMDS) coordinates were calculated for two 140 axes based on Bray-Curtis distances using Scikit-learn (sklearn.manifold.MDS; 141 n_components=2, metric=False, max_iter=500, eps=1e-12, 142 dissimilarity='precomputed'). 143
144

Percentile Normalization 145
In this procedure, control feature distributions are percentile-normalized against 146 themselves (resulting in a uniform distribution between 0 and 100) and case 147 feature distributions are converted into percentiles of their equivalent control 148 features. Treating our controls as null-hypotheses is motivated by the idea that 149 healthy patients should be treated as similar across datasets, even though we 150 understand that they will differ due to biological as well as technical batch effects. 151
Relative abundance distributions were converted to percentiles using the SciPy v 152 0.19.0 [40] stats.percentileofscore method (kind='mean'). In order to avoid rank 153 pile-ups due to the presence of many zeros, we replaced zeros with pseudo 154 relative abundances drawn from a uniform distribution between 0.0 and 10 -9 (i.e. 155 a set of random values smaller than the lowest possible relative abundance in 156 any dataset). Due to the zero-replacement step, p-values can shift slightly upon 157 re-analysis with a different random draw, which can lead to the loss or gain of 158 significance for features very near the significance threshold. Within each study,control distributions for each individual OTU or genus were converted into 160 percentiles of themselves and case distributions were converted into percentiles 161 of their corresponding control distribution. We have written a python script that 162 performs percentile-normalization given an OTU In addition to ComBat, we applied a linear batch correction method from the 179 limma package in R [5] . Relative abundances (zeros replaced with pseudo 180 relative abundances equal to half the minimal frequency across the entire feature 181 table) were log-transformed as described above and then a linear model was fitto subtract batch effects using the removeBatchEffect function (default settings). 183
The limma-corrected data were then transformed back from log-space (i. We ran an in silico titration experiment using the OTU-level data to 211 simulate pooling of control samples from different datasets before calculating 212 significant differences. Healthy samples from one study were mixed with healthy 213 samples from another study at different proportions prior to calculating significant 214 differences in OTU frequencies between cases and controls. Case and control 215 groups were subsampled to 40 samples each. Control samples were substituted 216 by randomly selected samples from another study along a fractional gradient (0-217 100% control samples from another study). We calculated significant differences 218 between case and control groups using the Wilcoxon rank-sum test and applied 219 an FDR correction. OTUs with q-values ≤ 0.05 were considered significant. The 220 titration experiment was rerun 20 times, and the results were averaged. corrected, and ComBat-corrected). We then calculated significant differencesbetween these artificial 'case' and 'control' groups as outlined above to generate 228 p-values for each OTU. 229
230
Results
231
Batch effects at OTU-level resolution 232
To minimize possible biases across data sets, we identified three colorectal 233 cancer (CRC) studies that sequenced the same region of the 16S gene (V4). We 234 reprocessed the raw sequence data from each study in the same quality filtering 235 and OTU picking pipeline to obtain bioinformatically-standardized results. OTUs 236 that occurred in at least one third of case or one third of control samples (i.e. 237 within individual studies) were retained for all downstream statistical analyses. 238
Despite standardizing the bioinformatic processing of these data, we saw 239 significant batch effects in healthy patients across studies (PERMANOVA p < 240 0.001; Fig. 2 ). The similarity between samples from the Baxter et al. (2016) and 241 et al. (2014) studies is due to the fact that they were sourced from the 242 same patient cohort (although samples were processed separately), making this 243 comparison a good pseudo-negative control for batch effects [18, 20] . There was 244 an apparent reduction in the batch effect after applying ComBat, although 245 differences between batches remained weakly significant (PERMANOVA p = 246 0.008, relative abundance OTU-level data). Despite standardized bioinformatic 257 processing, healthy patients differed significantly in their gut microbiomes across 258 studies (PERMANOVA p < 0.001; batch accounts for 6.342% of the total 259 variance). Studies were still significantly different after applying ComBat, an 260 established batch-correction method (PERMANOVA p < 0.01). However, 261
Zackular
percentile-normalization did a better job of stabilizing the variance across studies 262 and removed any apparent batch effect (PERMANOVA p > 0.5).
264
We ran an in silico titration experiment to simulate pooling of control 265 samples from different datasets before calculating significant differences. Healthy 266 samples from one study were mixed with healthy samples from another study at 267 different proportions prior to calculating significant differences in OTU 268 frequencies between cases and controls (see conceptual outline in Fig. 3 ). For 269 non-normalized data, the number of significant OTUs greatly increased due to 270 batch effects as more control samples were substituted in from another study. 271
This result highlights the danger of pooling raw data across batches. ComBat-272 and limma-corrected data performed better than uncorrected data, but still 273 showed many spurious results as the proportion of control samples from another 274 study increased (Fig. 3) . Percentile-normalization showed no increase in 275 spurious results over the titration gradient (Fig. 3) . Although we do see several 276
significant CRC-associated OTUs in the full dataset (see below), these were not 277 detected in the titration experiment due to the loss of statistical power when 278 rise to many spurious associations. The control group from one study is 283 gradually substituted with randomly chosen control samples from another study 284 (non-normalized, percentile-normalized, limma-corrected, and ComBat-285 corrected), keeping the total number of case and control samples fixed at n=40 286 (see conceptual illustration on the left). Mixing in non-normalized control samples 287 from another study gave rise to spurious results due to batch effects (blue lines). 288
ComBat-and limma-corrected data showed fewer spurious associations (green 289 and red lines). Percentile-normalization showed no increase in spurious results 290 along the titration gradient (orange lines).
292
We ran a second in silico experiment to determine whether the false-293 positive rate was impacted by our different batch-correction methods. We 294 'controls' and 40 samples from the Zeller healthy controls as artificial 'cases' for 296 each data type (i.e. non-normalized, percentile-normalized, limma-corrected, and 297
ComBat-corrected) and calculated significant OTU-level differences between 298 these groups. We repeated this process twenty times to generate a set of p-value 299 distributions. We found that the fraction of p-values ≤ 0.05 can be as high as 300 ~70% for the non-normalized data (Fig. 4) . This result matches with our finding 301 that 681 out of the 1,021 OTUs in this dataset differed significantly across Baxter 302
and Zeller controls (q ≤ 0.05). Each normalization technique drastically reduced 303 the number of false positives, but percentile-normalization gave the best results 304 (Fig. 4) . When low-abundance OTUs were included in the analysis, ComBat and 305 limma showed highly skewed p-value distributions, giving rise to a larger number 306 of false positives than the non-normalized data (Fig. S1) . 307 Lachnospiraceae family that were enriched in controls and one Lachnospiraceae 356 that was enriched in cases, which were missed by the within-study analyses. In 357 all, 18 OTUs were identified in the pooled, percentile-normalized results that 358 were missed by the within-study analyses (Fig. 5) . These additional taxonomicassociations (e.g. Desulfovibrio, Costridium XIVa, and Lachnospiraceae) are 360 consistent with prior meta-analyses of CRC microbiome studies [17, 43] . It is 361 important to visualize the data being fed into statistical tests to determine 362 whether significant associations are being driven by outlier studies or by other 363 artifacts. The associations identified in Figure 5 appear to be biologically 364 meaningful due to the overall consistency of the effect directions across studies. 365 366 367 Figure 5 . OTUs significant across CRC studies, but not within a given 368 study. Pooling data provides greater statistical power to detect subtle, yet 369 consistent differences in OTU abundances across sample groups. 18 OTUs are 370 labeled by their most resolved taxonomic annotation. Each OTU in this plot was 371 not found to be significant within either Baxter or Zeller studies, but became 372 significant after pooling the percentile-normalized datasets (q ≤ 0.05).
374 375
Batch effects at genus-level resolution across multiple diseases 376
In order to assess the performance of different meta-analysis techniques across 377 a larger set of studies and diseases, we summarized OTU abundances at the 378 Most genera that differed significantly within a given study were not 403 significant in other studies of the same disease. For example, of the 36 unique 404 genera that showed significant differences within any given OB study, none were 405 found to be significant in all studies (I = 0; Table 1 ). Indeed, there were no genera 406 that were significant across all studies in the majority of diseases studied (I = 0; 407 Table 1 ). CDI only had two studies, and of the 38 significant results, only six were 408 shared across both datasets. Overall, few genera were significant within two or 409 more studies (2N ≤ 6; Table 1) . 410
The number of genera that differed significantly across pooled cases and 411 controls changed depending on how the data were batch-corrected (Table 1 and  412   Table S1 ). For every disease, percentile-normalization yielded the largest 413 number of significant genera when compared to other methods. Overall, 414
ComBat-and limma-corrections resulted in many fewer significant genera, 415 especially for CD, UC, and CRC (Table 1 and Table S1 ). Half of the IBD (CD and 416 UC) studies included non-IBD patients with inflammatory symptoms as controls 417 rather than clinically healthy patients. These biologically relevant differences in 418 inflammatory symptoms between control cohorts were conflated with batches 419 and were likely smoothed out by ComBat and limma corrections. Fisher's and 420
Stouffer's methods consistently identified fewer significant associations than 421 percentile-normalization (Table 1 and Table S1 Numbers of genera that differ significantly between cases and controls for five 430 diseases. In the 'disease' column, CDI = Clostridium difficile induced diarrhea, 431 CD = Crohn's Disease, UC = Ulcerative Colitis, CRC = Colorectal Cancer, and 432 OB = obesity. 'N =' shows the number of studies included in each meta-analysis.
433
The method column indicates how the data were processed prior to running 434 significance tests (percentile-normalized, Fisher's method for combining p-435 values, Stouffer's method for combining p-values, ComBat-corrected, or limma-436 corrected). The significance threshold used was q ≤ 0.05 (FDR). The 'pooled' 437 column shows the total number of genera that were found to be significantly 438 different across pooled studies for a given disease. The 'within' column shows 439 the total number of unique (non-redundant) genera that were identified as 440 significantly different within each study (U = union), the number of genera that 441 were significant in all individual studies (I = intersection), and the number of 442 significant genera that were consistently significant in at least two studies (2N; 443 2N == I for CDI).
445
To better assess how percentile normalization impacted the pooled 446 results, we looked at genera that were significant within a single-study but not 447 across studies after pooling. There were 12 genera that were significant within a 448 subset of CRC studies, but not after pooling (Fig. 6) . Gemmiger, Bacteroides, 449 and Roseburia showed variable responses across studies, sometimes enriched 450 in controls and other times enriched in cases. The remaining genera showed 451 weak associations within one or two studies, but did not differ significantly across 452 studies (i.e. q ≤ 0.05). These genera that show weak or inconsistent responses 453 across batches may not be reliable disease biomarkers. However, by including 454 larger numbers of CRC studies in future meta-analyses it is likely that some of 455 these genera could pass the significance threshold. Two genera -Lactobacillus 456
and Desulfovibrio -were not significantly different between cases and controls 457 within an individual study, but became significant after pooling (Fig. 7) . These 458 genera showed weak, but largely consistent enrichment in cancer patients and 459 demonstrate the utility of pooling datasets to detect subtle differences. 460 Figure 6 . Genera that show a significant difference between CRC cases and 462 controls within a given study, but not after pooling. 12 genera showed 463 significant differences between cases and controls within a study (q ≤ 0.05), but 464 not after pooling across CRC studies. 465 466 467
468
Figure 7. Genera that do not show a significant difference between CRC 469 cases and controls within a given study, but do after pooling. Two genera 470 did not show significant differences between cases and controls within a study, 471 but became significant after pooling across CRC studies (q ≤ 0.05).
473
While prior work has suggested that there may not be consistent 474 associations between the gut microbiome and obesity [35] , we observed six 475 genera in a recent meta-analysis that differed significantly across two or more 476 (out of five) independent obesity studies [17] . Of these six genera, four 477 (Roseburia, Clostridium IV, Oscillobacter, and Pseudoflavonifractor) were also 478 found to be significant in the pooled, percentile-normalized results (Table S1 ; Fig.  479 S2). The two remaining genera not found to be significant in the percentile-480 normalized analysis (Mogibacterium and Anaerovorax) showed highly irregular 481 responses across the 11 obesity studies analyzed in this study (Fig. S3) . Despite 482 the irregular behavior of these genera, Fisher's and Stouffer's methods both 483
identified Mogibacterium as significantly associated with obesity (Table S1) . and by converting the case data into percentiles of the control distribution these 496 effects are attenuated without making parametric assumptions. 497
Relative abundance, limma-corrected, and ComBat-corrected data -but 498 not percentile-normalized data -quickly yielded a large number of spurious 499 results when cases from one study were tested against controls from another 500 (Fig. 3) . Additionally, when control populations from different batches werecompared to one another, non-normalized data yielded a much larger number of 502 false positives than batch-corrected data (Fig. 4) . Our percentile-normalization 503 approach was much more effective than limma and ComBat in controlling false 504 positives (Fig. 4) , especially in the presence of low-abundance taxa (Fig. S1) . 505
Because pooling datasets increases statistical power, it is tempting to pool 506 these data even in the absence of suitable batch-correction methods. 507
Consequently, pooling non-normalized data from different batches has been 508 common practice in the microbiome field [27, 29, 35, [47] [48] [49] [50] [51] [52] [53] [54] [55] . In this paper, we 509 demonstrate why this practice is highly inadvisable. Pooling batch-corrected data 510 from multiple studies allowed us to detect significant differences that were not 511 found within a given study (Figs. 5 and 7) , while removing associations that were 512 weak or inconsistent across studies (Fig. 6 and S3 ). Percentile-normalized 513 results often identified significant differences between cases and controls that 514 were missed by other normalization methods (Table 1) . For CDI, percentile-515 normalized results identified about the same number of significant hits as the 516 other batch-correction methods (Table 1) , which was likely due to the fact that 517 the biological signal associated with diarrhea is very strong [17] . In cases where 518 the biological signal is strong, results should be robust to the types of analyses 519 employed. For UC and CD studies (IBD), percentile-normalization identified 520 several significant genera that limma and ComBat did not (Table 1) . The reduced 521 number of significant hits from limma-and ComBat-corrected data for IBD was 522 likely due to heterogeneous control cohorts across these studies (i.e. healthy 523 patients vs. non-IBD patients), which likely smoothed-out inflammation-524 associated signals. This result highlights the importance of having consistent 525 definitions for case and control cohorts across studies. 526
We compared percentile-normalization and pooling to Fisher's and 527
Stouffer's methods for combining independent p-values. Stouffer's method is 528 similar to Fisher's, but includes weights for each p-value based on the number of 529 samples in a study. Percentile-normalization consistently identified a larger 530 number of significant hits than Stouffer's and Fisher's methods, confirming that 531 pooling data increases sensitivity (i.e. reducing putative false negatives). 532
Methods for combining p-values from independent studies are quite robust and 533 should probably be considered as a safe alternative to pooling (i.e. lower chance 534 of false positives). However, in the case of our obesity analysis, Fisher's and 535
Stouffer's methods identified Mogibacterium as significant despite its apparent 536 inconsistency across studies (Fig. S3) . 537
In conclusion, we present a robust, model-free procedure for transforming 538 each feature in a microbiome case-control dataset into percentiles of its control 539 distribution (Fig. 1) . The main conditions for applying this method are that 1) each 540 batch must have a sizeable number of control samples (i.e. the density of the 541 control distribution limits the resolution of the percentile-transformation of the 542 case samples), and 2) case and control populations should be consistently 543 defined across batches (i.e. same definition of 'healthy' or 'diseased' groups). 544
Given these caveats, percentile-normalized features can be pooled across 545 studies for univariate statistical testing (whichever test a researcher prefers -546 ideally non-parametric), alleviating the batch effect problem. This model-freeprocedure could also be applied to other types of 'omics datasets with 548 consistently defined internal controls. We find that this procedure allows us to 549 identify differences between cases and controls that are often missed by more 550 conservative meta-analysis techniques. Methods developed for batch-correction 551 in microarray data, like limma and ComBat, can partially reduce batch effects in 552 microbiome studies (Figs. 2-4) , but appear to obscure real patterns if batch 553 effects are not independent of biological signals or if the parametric assumptions 554 of these models are not valid. We suggest that methods like limma and ComBat 555 are useful for studies lacking case and control groups. However, when studies 556 have consistently defined internal controls, percentile-normalization should be 557 the preferred batch correction approach. Future work should focus on developing 558 parametric models specifically for batch correction in microbiome datasets, which 559 could further improve sensitivity to detect subtle biological differences across 560 studies. 561
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